ETHOS-TECH LTD

Company number 15219546 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ETHOS-TECH LTD - Analysis Report

Company Number: 15219546

Analysis Date: 2025-07-20 16:18 UTC

Financial Health Assessment of ETHOS-TECH LTD


1. Financial Health Score: D

Explanation:
ETHOS-TECH LTD currently exhibits significant financial distress indicated by negative net assets and working capital. As a newly incorporated micro entity, it is not unusual to face initial financial challenges; however, the current liquidity and solvency position suggests urgent attention is needed to stabilize the company’s finances. The score "D" reflects a warning status where the business is at risk but may recover with timely intervention.


2. Key Vital Signs

Metric Value (£) Interpretation
Current Assets 3,252 Limited short-term resources to cover debts.
Current Liabilities 9,571 Obligations due soon exceed available assets.
Net Current Assets (Working Capital) -6,319 Negative working capital indicates liquidity strain.
Net Assets (Shareholders' Funds) -6,319 Company’s liabilities exceed assets, showing insolvency on paper.
Average Number of Employees 2 Small workforce, consistent with micro entity.
Account Category Micro Simplified reporting, but financial challenges remain.

Interpretation:

  • Negative working capital is a critical symptom of financial distress, akin to a patient with low blood pressure and poor circulation — the company lacks sufficient liquid resources to meet short-term obligations.
  • Negative net assets indicate the company’s liabilities outweigh its assets, similar to a patient whose vital organs are under severe stress. This can limit the company’s ability to raise funds or secure credit, creating a liquidity trap.
  • The company is very young (incorporated October 2023) and likely in an early investment phase; initial losses and negative equity are somewhat expected but require close monitoring.

3. Diagnosis

ETHOS-TECH LTD is currently in a fragile financial state with critical symptoms of liquidity shortage and insolvency reflected in its negative net assets and working capital. This "financial illness" is typical for start-ups, especially in tech consultancy where upfront costs and operating expenses might precede revenue generation. However, the absence of an audit and limited financial disclosures (micro entity regime) restricts the depth of diagnosis.

The company’s current cash and assets are insufficient to cover its short-term debts, indicating a risk of default if additional funding or revenue does not materialize soon. This state could worsen if not addressed, potentially leading to formal insolvency procedures.


4. Recommendations

  1. Immediate Cash Flow Management:

    • Implement strict cost controls to conserve cash.
    • Prioritize payments and negotiate extended terms with creditors to ease short-term pressures.
  2. Capital Injection:

    • Seek additional equity investment from existing shareholders or new investors to restore positive net assets.
    • Consider short-term loans or overdrafts with flexible repayment terms.
  3. Revenue Generation Focus:

    • Accelerate client acquisition and project delivery to improve cash inflows.
    • Explore prepayment or milestone billing to improve liquidity.
  4. Financial Monitoring & Reporting:

    • Maintain detailed cash flow forecasts and regularly review financial health metrics.
    • Even though audit is not mandatory, consider voluntary financial reviews to reassure stakeholders.
  5. Strategic Business Planning:

    • Assess business model scalability and cost structure to ensure sustainable growth.
    • Prepare contingency plans for liquidity crises.

Medical Analogy Summary

ETHOS-TECH LTD’s financial condition is akin to a patient in the early stages of illness with symptoms of dehydration and weakness—low cash (blood supply) and a negative net worth (organ stress). Immediate "treatment" (cash management and capital injection) is essential to stabilize before recovery (profitability) can be expected.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.